SERETIDE

This brand name is authorized in Austria, Australia, Brazil, Cyprus, Germany, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Israel, Italy, Lithuania, Malta, Mexico, Nigeria, Netherlands, New Zealand, Poland, Romania, Singapore, Tunisia, Turkey, United Kingdom, South Africa

Active ingredients

The drug SERETIDE contains a combination of these active pharmaceutical ingredients (APIs):

1 Salmeterol UNII 6EW8Q962A5 - SALMETEROL XINAFOATE

Salmeterol is a selective long-acting (12 hour) β2 adrenoceptor agonist. These pharmacological properties of salmeterol offer more effective protection against histamine-induced bronchoconstriction and produce a longer duration of bronchodilation, lasting for at least 12 hours, than recommended doses of conventional short-acting β2 agonists. Read about Salmeterol

2 Fluticasone UNII O2GMZ0LF5W - FLUTICASONE PROPIONATE

Fluticasone has anti-inflammatory and vasoconstrictive features. Fluticasone given by inhalation at recommended doses has a potent glucocorticoid anti-inflammatory action within the lungs, resulting in a reduction of both symptoms and exacerbations of asthma, with a lower incidence and severity of adverse effects than those observed when corticosteroids are administered systemically. Read about Fluticasone

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
SERETIDE Inhaler	Medicines and Medical Devices Safety Authority (NZ)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
R03AK06	Salmeterol and fluticasone	R Respiratory system → R03 Drugs for obstructive airway diseases → R03A Adrenergics, inhalants → R03AK Adrenergics and other drugs for obstructive airway diseases
Discover more medicines within R03AK06

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 8430Q, 8431R, 8432T, 8517G, 8518H, 8519J
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 510607001177311, 510607002173318, 510607003171319, 510607004176314, 510607005172312, 510607006179310, 510611801174313, 510611802170311
Country: DE	Bundesinstitut für Arzneimittel und Medizinprodukte	Identifier(s): 06815849, 06815884, 06815921, 11175518, 15655988, 15655994
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 1919-MEE-0316, 1984-MEE-0416, 29725-04-11, 29726-04-11, 29727-04-11, 7241-MEE-0522, 7479-MEE-0922
Country: EE	Ravimiamet	Identifier(s): 1037595, 1037607, 1107335, 1107346, 1107357, 1153167, 1528185, 1528196, 1528208, 1711370, 1711392, 1711415, 1711426, 1711448, 1711460, 1711471, 1711493, 1711516
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 62667, 62668, 62669, 63796, 63797, 63798
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 003870, 003948, 003959, 034978, 034987, 034996, 552612, 552620, 552646
Country: FR	Base de données publique des médicaments	Identifier(s): 60569419, 61073237, 61572165, 64461896, 64587838, 67546191, 69505268
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 139976, 139985, 146742, 146748, 162412, 162414, 162416, 162445, 181859, 186115, 28300, 28308, 28310, 31870, 31873, 31884, 374433, 374435, 374437, 374441, 377023, 377025, 377027, 379966, 379969
Country: HK	Department of Health Drug Office	Identifier(s): 44734, 44735, 44736, 48128, 48129, 48130
Country: HR	Agencija za lijekove i medicinske proizvode	Identifier(s): HR-H-251056275, HR-H-491933173, HR-H-513256189, HR-H-562619185, HR-H-572113579
Country: IE	Health Products Regulatory Authority	Identifier(s): 45311, 45378, 45622, 45644, 45699, 53413, 54830, 56603, 60025, 60039, 60044, 72803, 72871, 72880, 72882
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 4126, 4127, 4128
Country: IT	Agenzia del Farmaco	Identifier(s): 034371043, 034371056, 034371068, 034371106, 034371118, 034371120
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1002834, 1002835, 1002836, 1003487, 1003497, 1003498, 1003841, 1058265, 1058268, 1073216, 1073217
Country: MT	Medicines Authority	Identifier(s): MA192/00901, MA192/00902, MA192/00903, MA192/00905, PI1438/07701A, PI1438/07702A, PI908/21701A, PI908/21702A, PI908/21703A
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 018M2001, 340M99
Country: NG	Registered Drug Product Database	Identifier(s): 04-6850, B4-9735
Country: NL	Z-Index G-Standaard	Identifier(s): 14254166, 14254174, 14254182, 14642786, 14642794, 14642808
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 62510, 62529, 62537, 64955, 64963, 64971
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 8417, 8418, 8419, 9639, 9640, 9641
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100097404, 100097410, 100097427, 100104989, 100104995, 100105003
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W65108001, W65108002, W65108003, W65108004, W65108005, W65109001, W65109002, W65109003, W65109004, W65109005, W65110001, W65110002, W65110003, W65110004, W65110005, W65217001, W65218001
Country: SG	Health Sciences Authority	Identifier(s): 11030P, 11031P, 11032P, 11529P, 11530P, 11531P
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 5163101, 5163102, 5163103, 5163111
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699522523078, 8699522523085, 8699522553242, 8699522553259, 8699522553266
Country: ZA	Health Products Regulatory Authority	Identifier(s): 33/21.5.4/0413, 33/21.5.4/0414, 33/21.5.4/0415, 35/21.5.4/0411, 35/21.5.4/0412, 35/21.5.4/0413